DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 3.32% to $11.08 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.29% to 26,506.99 and Dow Jones Industrial Average falling 0.51% to 53,414.25.
This was the stock's second consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 46.11% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock underperformed when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 1.69% to $5.43, Fortress Biotech Inc. (FBIO) rose 0.37% to $2.72, and Viking Therapeutics Inc. (VKTX) rose 2.62% to $34.87.
Trading volume (222,466) remained 232,334 below its 50-day average volume of 454,800.
Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2026.
Comments